Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.58
Delayed Data
As of 4:00pm ET
 +0.37 / +1.02%
Today’s Change
30.90
Today|||52-Week Range
36.82
+12.62%
Year-to-Date
Spark Therapeutics Stock Plunges on Hemophilia Therapy Data
11:01am / Zacks.com - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content
US Market Indexes Higher on Monday
10:38am / GuruFocus News - Paid Partner Content
Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend
Dec 08 / TheStreet.com - Paid Partner Content
Teva Stock Rises After Announcing Launch of Generic Viagra Competitor
Dec 11 / TheStreet.com - Paid Partner Content
Pfizer Reports Updated Data from Phase III Study on Ibrance
Dec 07 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Talazoparib Emerges Superior in EMBRACA Study
Dec 11 / Zacks.com - Paid Partner Content
Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?
Dec 06 / Zacks.com - Paid Partner Content
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Dec 11 / TheStreet.com - Paid Partner Content
5 Top-Ranked Drug Stocks that are Broker Favorites
Dec 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close36.21
Today’s open36.36
Day’s range36.25 - 36.82
Volume22,485,913
Average volume (3 months)16,075,800
Market cap$215.8B
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+8.12%
Earnings growth (next 5 years)+6.01%
Revenue growth (last year)+8.13%
P/E ratio22.6
Price/Sales3.79
Price/Book3.69

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.66+0.79%
MRKMerck+0.73+1.30%
SNYSanofi+0.26+0.59%
ABBVAbbVie-0.17-0.18%
Data as of 4:02pm ET, 12/12/2017

Financials

Next reporting dateJanuary 30, 2018
EPS forecast (this quarter)$0.56
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts